ASDS Ascendant Solutions

Dougherty’s Pharmacy, Inc. Announces Approval of Proposals at 2018 Annual Meeting of Stockholders

Dougherty’s Pharmacy, Inc. Announces Approval of Proposals at 2018 Annual Meeting of Stockholders

DALLAS, June 15, 2018 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (the “Company”) or (“Dougherty’s”) (OTCQB:MYDP) today announced that the Company held its rescheduled 2018 Annual Meeting of Stockholders on June 12, 2018, at which the Company’s stockholders voted in favor of both proposals by the Company.

The Company’s stockholders voted to elect Troy Phillips as a Class A Director to hold office until the 2021 annual meeting of stockholders and to ratify the selection of Whitley Penn LLP to be the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.

About Dougherty’s Pharmacy, Inc.

Dougherty’s Pharmacy, Inc. is a retail pharmacy chain focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region of the United States. On June 9, 2017, the Company changed its name from Ascendant Solutions, Inc. to Dougherty’s Pharmacy, Inc. to better reflect the corporate vision and operating structure. Dougherty’s currently has approximately $48 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Dougherty’s at OTCMarkets.com or at .  

Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's current expectations, projections, estimates and assumptions. These forward-looking statements may be identified by words such as "expects," "believes," "anticipates" and similar expressions.  Forward-looking statements involve risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements.  The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.

Contacts:    

Geralyn DeBusk or Tom Carey  

Halliburton Investor Relations  

972-458-8000

EN
15/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ascendant Solutions

 PRESS RELEASE

Dougherty’s Pharmacy, Inc. Announces Results of 2019 Annual Stockhol...

Dougherty’s Pharmacy, Inc. Announces Results of 2019 Annual Stockholders’ Meeting DALLAS, June 11, 2019 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (OTCPK: MYDP) (“Dougherty’s” or the “Company”) today announced the results of its 2019 Annual Meeting of Stockholders, held June 10, 2019, in Dallas. The Company’s shareholders elected Anthony Levecchio and Will Cureton to each serve as a director until the 2020 Annual Meeting of Stockholders and until his successor has been duly elected and qualified to hold office. In addition, the board of directors has appointed Troy Phillips to serve...

 PRESS RELEASE

Dougherty’s Pharmacy, Inc. Provides Update on Recent Strategic Initi...

Dougherty’s Pharmacy, Inc. Provides Update on Recent Strategic Initiatives DALLAS, June 07, 2019 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (OTCPK: MYDP) (“Dougherty’s” or the “Company”) today confirmed that the previously announced transaction to sell the prescription files of three Dougherty’s pharmacy locations to a national Fortune 500 pharmaceutical and healthcare retail company did not close as expected. The Company is continuing to explore strategic alternatives with respect to these locations. Stewart Edington, President and CEO of Dougherty’s, said, “We are undertaking a num...

 PRESS RELEASE

Dougherty’s Pharmacy, Inc. Announces Agreement to Sell Prescription...

Dougherty’s Pharmacy, Inc. Announces Agreement to Sell Prescription Files of Three Pharmacy Locations for $2.7 Million Proceeds To Be Used for Debt Reduction DALLAS, May 10, 2019 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (OTCPK: MYDP) (“Dougherty’s” or the “Company”) today announced the signing of an agreement to sell the prescription files of three locations to a national Fortune 500 pharmaceutical and healthcare retail company.  The Company anticipates receiving proceeds of $2.7 million to be paid at closing, with an additional $300,000 retention earnout to be received one year a...

 PRESS RELEASE

Dougherty’s Pharmacy, Inc. Appoints New Members to the Board of Dire...

Dougherty’s Pharmacy, Inc. Appoints New Members to the Board of Directors DALLAS, March 28, 2019 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (OTCPK: MYDP) (“Dougherty’s” or the “Company”) today announced the appointment of three new members to the company’s board of directors: Joseph J. Flynn, President and CEO of Vereco Inc.; Joshua Womack, Principal and Investment Manager of Womack Financial; and Stewart Edington, President and Chief Executive Officer of Dougherty’s. Joseph “Joe” Flynn has served as the President and CEO of Vereco Inc., a Southern California based Healthcare IT Serv...

 PRESS RELEASE

Dougherty’s Pharmacy, Inc. Appoints New President and Chief Executiv...

Dougherty’s Pharmacy, Inc. Appoints New President and Chief Executive Officer; Engages Experienced Business Consultant to Act as Advisor to the Board of Directors DALLAS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (OTCPK: MYDP) (“Dougherty’s” or the “Company”) today announced it has named Stewart Edington as the Company’s new President and Chief Executive Officer. In addition, Edington will also assume interim duties as Chief Financial Officer. Edington brings over 30 years of experience in the pharmacy industry leading some of the largest pharmacy chains in the United ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch